scholarly article | Q13442814 |
P2093 | author name string | Iryna Sorokulova | |
Darya Starosila | |||
Ludmila Varbanetz | |||
Naila Ivanskaya | |||
Svetlana Rybalko | |||
P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
Proteomics characterization of abundant Golgi membrane proteins | Q28141807 | ||
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis | Q28258829 | ||
In-gel digestion for mass spectrometric characterization of proteins and proteomes | Q29547583 | ||
Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells | Q30357092 | ||
Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): A meta-analysis. | Q30385184 | ||
An update on the use and investigation of probiotics in health and disease | Q30407565 | ||
Bioactive microbial metabolites | Q31157729 | ||
Viral exploitation and subversion of the immune system through chemokine mimicry | Q33933260 | ||
In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. | Q33983372 | ||
Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow | Q34002643 | ||
Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin | Q34424372 | ||
Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. | Q35771988 | ||
Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity | Q35901914 | ||
Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. | Q36799919 | ||
Microbiota restoration: natural and supplemented recovery of human microbial communities | Q37813012 | ||
Probiotics and health: an evidence-based review | Q37846909 | ||
Probiotics in respiratory virus infections. | Q38196730 | ||
Antimicrobial peptides of the genus Bacillus: a new era for antibiotics. | Q38335550 | ||
Influenza in the Emergency Department: Vaccination, Diagnosis, and Treatment: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines Committee | Q38695796 | ||
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an example | Q40136000 | ||
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells | Q40231712 | ||
Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14. | Q40693087 | ||
Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients | Q41626984 | ||
Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice | Q41653544 | ||
Oral intake of Lactobacillus rhamnosus M21 enhances the survival rate of mice lethally infected with influenza virus | Q41706073 | ||
Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine | Q44348398 | ||
The efficacy of the new bacterial preparation biosporin in treating acute intestinal infections | Q50140899 | ||
Structural and functional studies of Peptide-carbohydrate mimicry. | Q51054716 | ||
Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. | Q52527435 | ||
Probiotics against Campylobacter Pathogens | Q77553286 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Bacillus subtilis | Q131238 |
probiotics | Q1816730 | ||
P577 | publication date | 2017-06-27 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Anti-influenza Activity of a Bacillus subtilis Probiotic Strain | |
P478 | volume | 61 |
Q47159058 | Amelioration of the DSS-induced colitis in mice by pretreatment with 4,4'-diaponeurosporene-producing Bacillus subtilis |
Q64900236 | Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies. |
Q98578835 | The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment? |
Search more.